Skip to main content
Top
Published in: Cancer Causes & Control 5/2003

01-06-2003

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

Authors: Joseph A. Tangrea, Paul S. Albert, Elaine Lanza, Karen Woodson, Don Corle, Marsha Hasson, Randall Burt, Bette Caan, Electra Paskett, Frank Iber, J. Walter Kikendall, Peter Lance, Moshe Shike, Joel Weissfeld, Arthur Schatzkin

Published in: Cancer Causes & Control | Issue 5/2003

Login to get access
Metadata
Title
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)
Authors
Joseph A. Tangrea
Paul S. Albert
Elaine Lanza
Karen Woodson
Don Corle
Marsha Hasson
Randall Burt
Bette Caan
Electra Paskett
Frank Iber
J. Walter Kikendall
Peter Lance
Moshe Shike
Joel Weissfeld
Arthur Schatzkin
Publication date
01-06-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Cancer Causes & Control / Issue 5/2003
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1024990617158

Other articles of this Issue 5/2003

Cancer Causes & Control 5/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine